You are here: Home » News-CM » Companies » Results
Business Standard

Medicamen Biotech standalone net profit rises 7.87% in the September 2019 quarter

Capital Market 

Sales rise 9.33% to Rs 35.52 crore

Net profit of Medicamen Biotech rose 7.87% to Rs 3.84 crore in the quarter ended September 2019 as against Rs 3.56 crore during the previous quarter ended September 2018. Sales rose 9.33% to Rs 35.52 crore in the quarter ended September 2019 as against Rs 32.49 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales35.5232.49 9 OPM %16.0512.71 -PBDT5.845.59 4 PBT5.225.11 2 NP3.843.56 8

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, November 08 2019. 16:44 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU